Sign in
4

Changes in Ownership

Parabilis Medicines, Inc. Filed Acc 0001193805-26-000798

10% owner acquired 1,880,704 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Flynn James E 10% owner 2026-06-11 Conversion +122,990 122,990 I: show line 1 in the form
Flynn James E 10% owner 2026-06-11 Conversion +122,990 122,990 I: show line 2 in the form
Flynn James E 10% owner 2026-06-11 Conversion +149,238 272,228 I: show line 3 in the form
Flynn James E 10% owner 2026-06-11 Conversion +149,238 272,228 I: show line 4 in the form
Flynn James E 10% owner 2026-06-11 Conversion +260,992 533,220 I: show line 5 in the form
Flynn James E 10% owner 2026-06-11 Conversion +260,992 533,220 I: show line 6 in the form
Flynn James E 10% owner 2026-06-11 Conversion +407,132 940,352 I: show line 7 in the form
Flynn James E 10% owner 2026-06-11 Conversion +407,132 940,352 I: show line 8 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Flynn James E 10% owner 2026-06-11 Conversion · Series A Preferred Stock −166,070 0 I: show line 9 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series A Preferred Stock −166,070 0 I: show line 10 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series B Preferred Stock −143,650 0 I: show line 11 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series B Preferred Stock −143,650 0 I: show line 12 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series C Preferred Stock −246,732 0 I: show line 13 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series C Preferred Stock −246,732 0 I: show line 14 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series D Preferred Stock −464,550 0 I: show line 15 in the form
Flynn James E 10% owner 2026-06-11 Conversion · Series D Preferred Stock −464,550 0 I: show line 16 in the form
Loading xslF345X06/e665575_4-pbls.xml…